Search Results

There are 20633 results for: content related to: Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Article first published online : 19 JUN 2012, DOI: 10.1002/mds.25051

  2. Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?

    Movement Disorders

    Volume 26, Issue 7, June 2011, Pages: 1187–1193, Carl E. Clarke, Smitaa Patel, Natalie Ives, Caroline Rick, Keith Wheatley and Richard Gray

    Article first published online : 14 APR 2011, DOI: 10.1002/mds.23519

  3. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Article first published online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Article first published online: 10 NOV 2010

  4. Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease

    Movement Disorders

    Volume 24, Issue 4, 15 March 2009, Pages: 564–573, Robert A. Hauser, Mark F. Lew, Howard I. Hurtig, William G. Ondo, Joanne Wojcieszek and Cheryl J. Fitzer-Attas

    Article first published online : 11 DEC 2008, DOI: 10.1002/mds.22402

  5. A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics

    Movement Disorders

    Volume 23, Issue 15, 15 November 2008, Pages: 2194–2201, C. Warren Olanow, Robert A. Hauser, Joseph Jankovic, William Langston, Anthony Lang, Werner Poewe, Eduardo Tolosa, Fabrizio Stocchi, Eldad Melamed, Eli Eyal and Olivier Rascol

    Article first published online : 19 OCT 2008, DOI: 10.1002/mds.22218

  6. Rationale for delayed-start study of pramipexole in Parkinson's disease: The PROUD study

    Movement Disorders

    Volume 25, Issue 11, 15 August 2010, Pages: 1627–1632, Anthony H.V. Schapira, Stefan Albrecht, Paolo Barone, Cynthia L. Comella, Michael P. McDermott, Yoshikuni Mizuno, Werner Poewe, Olivier Rascol and Kenneth Marek

    Article first published online : 11 JUN 2010, DOI: 10.1002/mds.23143

  7. Trial designs used to study neuroprotective therapy in Parkinson's disease

    Movement Disorders

    Volume 28, Issue 1, January 2013, Pages: 86–95, Anthony E. Lang, Eldad Melamed, Werner Poewe and Olivier Rascol

    Article first published online : 23 AUG 2012, DOI: 10.1002/mds.24997

  8. Washout and delayed start designs for identifying disease modifying effects in slowly progressive diseases using disease progression analysis

    Pharmaceutical Statistics

    Volume 8, Issue 3, July/September 2009, Pages: 225–238, Berend Arnold Ploeger and Nicholas H. G. Holford

    Article first published online : 24 NOV 2008, DOI: 10.1002/pst.355

  9. Milestones in movement disorders clinical trials: Advances and landmark studies

    Movement Disorders

    Volume 26, Issue 6, May 2011, Pages: 1003–1014, C. Warren Olanow, Kathryn B. Wunderle and Karl Kieburtz

    Article first published online : 27 MAY 2011, DOI: 10.1002/mds.23727

  10. Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Article first published online : 6 JUN 2014, DOI: 10.1002/mds.25914

  11. Poster Session 3

    Movement Disorders

    Volume 21, Issue S15, September 2006, Pages: S517–S613,

    Article first published online : 20 SEP 2006, DOI: 10.1002/mds.21248

  12. Defining disease-modifying therapies for PD—A road map for moving forward

    Movement Disorders

    Volume 25, Issue 12, 15 September 2010, Pages: 1774–1779, C. Warren Olanow and Karl Kieburtz

    Article first published online : 8 SEP 2010, DOI: 10.1002/mds.23288

  13. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Article first published online : 28 MAY 2008, DOI: 10.1002/mds.22133

  14. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Article first published online : 21 OCT 2011, DOI: 10.1002/mds.23829

  15. Clinical Pharmacology of Rasagiline: A Novel, Second-Generation Propargylamine for the Treatment of Parkinson Disease

    The Journal of Clinical Pharmacology

    Volume 45, Issue 8, August 2005, Pages: 878–894, Dr Jack J. Chen and Dr David M. Swope

    Article first published online : 19 MAR 2013, DOI: 10.1177/0091270005277935

  16. You have free access to this content
    How should we treat a patient with early Parkinson’s disease?

    International Journal of Clinical Practice

    Volume 64, Issue 9, August 2010, Pages: 1210–1219, S. Tsouli and S. Konitsiotis

    Article first published online : 13 JUL 2010, DOI: 10.1111/j.1742-1241.2010.02371.x

  17. Why have we failed to achieve neuroprotection in Parkinson's disease?

    Annals of Neurology

    Volume 64, Issue S2, December 2008, Pages: S101–S110, C. Warren Olanow, Karl Kieburtz and Anthony H. V. Schapira

    Article first published online : 6 JAN 2009, DOI: 10.1002/ana.21461

  18. Neuroprotection trials in Parkinson's disease: Systematic review

    Movement Disorders

    Volume 24, Issue 5, 15 April 2009, Pages: 647–654, Robert G. Hart, Lesly A. Pearce, Bernard M. Ravina, Toby C. Yaltho and John R. Marler

    Article first published online : 31 DEC 2008, DOI: 10.1002/mds.22432

  19. Early (Uncomplicated) Parkinson's Disease

    European Handbook of Neurological Management, Second Edition, Volume 1, Second Edition

    W. H. Oertel, A. Berardelli, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, J. J. Ferreira, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, Pages: 217–236, 2010

    Published Online : 6 SEP 2010, DOI: 10.1002/9781444328394.ch14

  20. Obstacles to the Development of a Neuroprotective Therapy for Parkinson's Disease

    Movement Disorders

    Volume 28, Issue 1, January 2013, Pages: 3–7, Fabrizio Stocchi and C. Warren Olanow

    Article first published online : 6 FEB 2013, DOI: 10.1002/mds.25337